Related Experiment Video
Updated: May 9, 2026

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
Published on: December 22, 2020
Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers
Kai Hung Tiong1, Li Yen Mah, Chee-Onn Leong
1School of Postgraduate Studies and Research, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia, kaihung_tiong@imu.edu.my.
Abstract:
The fibroblast growth factor receptors (FGFRs) regulate important biological processes including cell proliferation and differentiation during development and tissue repair. Over the past decades, numerous pathological conditions and developmental syndromes have emerged as a consequence of deregulation in the FGFRs signaling network. This review aims to provide an overview of FGFR family, their complex signaling pathways in tumorigenesis, and the current development and application of therapeutics targeting the FGFRs signaling for treatment of refractory human cancers.
Insights
Fibroblast growth factor receptors (FGFRs) are crucial for cell growth and repair. Dysregulation of FGFR signaling contributes to various cancers, leading to the development of targeted therapies.
Area of Science:
- Oncology
- Molecular Biology
- Developmental Biology
Background:
- Fibroblast growth factor receptors (FGFRs) play vital roles in cell proliferation, differentiation, development, and tissue repair.
- Aberrant FGFR signaling pathways are implicated in numerous pathological conditions, developmental syndromes, and tumorigenesis.
- Understanding FGFR signaling is critical for developing effective cancer treatments.
Purpose of the Study:
- To provide a comprehensive overview of the FGFR family.
- To elucidate the complex signaling pathways of FGFRs in tumorigenesis.
- To review the current development and application of FGFR-targeted therapeutics for refractory human cancers.
Main Methods:
- Literature review of scientific publications on FGFRs.
- Analysis of FGFR signaling pathways in cancer.
- Examination of current therapeutic strategies targeting FGFRs.
Main Results:
- FGFRs comprise a family of receptor tyrosine kinases with diverse roles in cellular processes.
- FGFR signaling deregulation is a common mechanism in various human cancers.
- Targeted therapies inhibiting FGFR signaling show promise in treating specific refractory cancers.
Conclusions:
- FGFRs are critical regulators of fundamental biological processes.
- Dysregulated FGFR signaling drives cancer development and progression.
- Targeting FGFRs represents a promising therapeutic strategy for refractory cancers, with ongoing development and clinical application.
Related Concept Videos
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical, 7TM, or...
TGF - β Signaling Pathway
Introduction to Fibroblasts

